Nestled in the heart of the Swiss Alps, the canton of Valais continues to position itself as a leader in the chemical and pharmaceutical industries. These sectors, symbols of innovation and economic growth, are deeply rooted in the canton’s culture of progress. They play a key role in the regional economy, occupying a dominant position and actively contributing to boosting the canton’s economic landscape.<\/p>\n\n\n\n
In 2023, the celebration of Valsynthese’s 40th anniversary in Brig<\/a> and the inauguration of Debiopharm’s new building in Martigny<\/a> testify to the vitality of the sector. These events underline the importance of the chemical-pharmaceutical industry, which generates 25% of the canton’s added value, surpassing even the tourism sector. With a significant impact on the canton’s GDP, this industry stands out for its ability to combine historical heritage with futuristic vision.<\/p>\n\n\n\n Similarly, companies such as the Soci\u00e9t\u00e9 Suisse des Explosifs (SSE), which has successfully diversified into fine chemicals via its subsidiary Valsynthese, illustrate the sector’s adaptability and innovation. Investing in infrastructure and expanding its international footprint, SSE Group symbolizes Valais’ ability to evolve and prosper. This diversification is also evident in the evolution of Valsynthese, which operates in a variety of fields including pharmaceuticals and technology.<\/p>\n\n\n\n